Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN151762 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Hypoxia Inducible Factor 1, alpha Subunit (Basic Helix-Loop-Helix Transcription Factor) (HIF1A) antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- HA111
- Vial size
- 0.1 mL
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia.
Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.
(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors.
Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization.
Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
Lee KE, Spata M, Bayne LJ, Buza EL, Durham AC, Allman D, Vonderheide RH, Simon MC
Cancer discovery 2016 Mar;6(3):256-69
Cancer discovery 2016 Mar;6(3):256-69
Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.
Rajakumar A, Michael HM, Daftary A, Jeyabalan A, Gilmour C, Conrad KP
Placenta 2008 Mar;29(3):290-9
Placenta 2008 Mar;29(3):290-9
(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors.
Lauzier MC, Robitaille GA, Chan DA, Giaccia AJ, Richard DE
Molecular pharmacology 2008 Jul;74(1):282-8
Molecular pharmacology 2008 Jul;74(1):282-8
Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
Gillespie DL, Whang K, Ragel BT, Flynn JR, Kelly DA, Jensen RL
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Apr 15;13(8):2441-8
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Apr 15;13(8):2441-8
Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization.
Zheng X, Ruas JL, Cao R, Salomons FA, Cao Y, Poellinger L, Pereira T
Molecular and cellular biology 2006 Jun;26(12):4628-41
Molecular and cellular biology 2006 Jun;26(12):4628-41
Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
Jensen RL, Ragel BT, Whang K, Gillespie D
Journal of neuro-oncology 2006 Jul;78(3):233-47
Journal of neuro-oncology 2006 Jul;78(3):233-47
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC